HEADLINES:
1. Trade pacts under lens as India seeks to check Chinese imports
2. Glenmark launches new coronavirus medicine at ₹103 per tablet. 10 things to know
3. Glenmark Pharma gains 15% on launch of Favipiravir, a potential Covid drug
4. India ‘pharmacy of the world’ during COVID-19: Shanghai Cooperation Organisation
5. Rerating candidate! RIL becomes 1st Indian company to hit m-cap of $150 billion
6. Importing these items from China may get difficult; govt mulls stricter curbs amid India-China faceoff
7. Pension fund FDI cap proposed at 49%
8. Mukesh Ambani joins club of world’s 10 richest
Click here for news summary